P E R S O N A L I Z E

“And it ought to be remembered that there is nothing more difficult to take in hand, more perilous to conduct, or

more uncertain in its success, than to take the lead in the introduction of a new order of things.”

Niccolò Machiavelli, The Prince

M E D I A K I T 2 0 1 7

Field Notes 2 short reports on new trends or developments in the Precision Medicine Field

Precision ToolsA review of the current tools and technologies that are enabling a deeper insight

into the mechanism of various diseases.

SNPshot A focus on a particular disease area and progress being made in the

advancement of new Precision Therapies.

Cognoscienti There are many important cogs that need to work in unison to drive the Precision Medicine

movement forward. We curate opinion from the thinkers in the fields of regulation, bioethics, health economics, policy and education.

The Hub A report on a region that is building public/private partnerships and promoting inward

investment to further the advancement of Precision Medicine.

2020We talk to a visionary about their career path in science, how it has shaped

their current perspective in this evolving field and ask for some predictions for the future of Precision Medicine.

1

2

4

5

Bi-Monthly Features

‘I believe the clinical application of precision medicine has the ability to positively impact patients across an array of medical disciplines. As precision medicine becomes an increasingly critical treatment paradigm,

physicians and providers throughout the world are seeking for sources of information on this topic. I believe the Journal of Precision Medicine has the opportunity to fill a significant

need in this regard and I am excited to participate on the Board.’

3

P E R S O N A L I Z E

6

Lincoln Nadauld Director, Cancer Genomics, Intermountain Healthcare

Jonathan KnowlesEx Head Global Pharma Research

RocheChairman Immunocore

Mark FidockVP Head of Personalized

Healthcare and Biomarker LabsAstra Zeneca

Anick DuboisDirector Personalized Medicine

Implementation CEPMED (Center of Excellence in Personalized Medicine)

Montreal Heart Institute

Edgar BraendleCEO & President ARUP Laboratories

Professor Gillies MckennaHead of Department of Oncology

Director CRUK/MRC Oxford Institute for Radiation Oncology

Katherine Johansen TaberDirector of Personalized Medicine

American Medical Association

Kathryn PhillipsProfessor of Health Economics and Health Services

Research Founder/Director of the UCSF Center for Translational and Policy Research

on Personalized Medicine (TRANSPERS)

Frank PrendergastFormer Director of Individualized Medicine Institute

Mayo Clinic

Marielena MataProgram Director, Precision Medicine and

Companion Diagnostics, GSK

Boris PascheDirector, Comprehensive Cancer Center and

Chairman, Department of Cancer Biology, Wake Forest University

Scott V. McGoohanDirector, Science and Regulatory Affairs

Biotechnology Industry Organization (BIO)

George PosteChief Scientist, Complex Adaptive Systems

at Arizona State University

David KlonoffMedical Director, Diabetes Research Institute,

Mills-Peninsula Health Services (Sutter Health)

Stephen NaylorFounder, Chairman, President Mai Health,

Indianapolis, IN

Deepak AsudaniAssociate Clinical Professor of Medicine

University of California, San Diego

Raymond McCauleyChair Biotechnology and Bioinformatics,

Singularity University

Catalina Lopez-CorreaChief Scientific Officer & Vice President

Genome British Columbia

Advisory Board Members

P E R S O N A L I Z E

Atul J. ButteDirector, Institute for Computational Health Sciences and Professor of PediatricsUniversity of California, San Francisco

Mark A. RubinDirector, Englander Institute for Precision Medicine at Weill Cornell Medicine

Dennis LoDirector of the Li Ka Shing Institute of Health Sciences, Li Ka Shing Professorof Medicine and Professir of Chemical Pathology of The Chinese University of Hong Kong

Stephen KingsmorePresident/CEO, Rady Pediatric Genomic and Systems Medicine Institute

Rupert VesseyPresident, Research & Early DevelopmentCelgene Corporation

Mara G. AspinallPresident and CEO of HealthCatalysts

Geoffrey S. GinsburgDirector Center for Applied Genomics and Precision Medicine, Duke University Medical Center

Hakan SakulVice President and Head of Diagnostics at Pfizer

Vincent FunariTechnical Director and Director of Bioinformatics for Molecular Lab at NeoGenomics Laboratories

Nicholas DracopoliVice President, Head Oncology Translational Research at Janssen R&D, Johnson & Johnson

Dietrich StephanChair of the Department of Human Genetics at the University of Pittsburgh, Graduate School of Public Health

Patrick TanSenior Group Leader, Genome Institute of Singapore, Senior Principal Investigator, Cancer Science Institute of Singapore

Isidore RigoutsosDirector - Computational Medicine, Sidney Kimmel Cancer Center,. Thomas Jefferson University

Jennifer Levin CarterFounder, N of One

Lincoln NadauldDirector, Cancer Genomics, Intermountain Healthcare

Eric LaiSenior VP, Head of Pharmacogenomics & Companion Diagnostics, Takeda Pharmaceuticals International, Inc.

Emanuel Petricoin IIIUniversity Professor at George Mason University, Co-Director Center for Applied Proteomics and Molecular Medicine

James CzabanChair, FDA Practice Group DLA Piper

14,500

8,500

2,000

US

A

Eu

rop

e

R o

f W

Geographical Breakdown

Total circulation 25,000*

USA

EUROPE

REST OF THE WORLD

P E R S O N A L I Z E*15,000 print and 10,000 digital

Industry 38%

Acade

mic 22%

Clinical 32%

Go

vern

men

t 5

%

Oth

er 3

%

Institution

Industry 38% Pharma/BioPharm/Biotech/CRO’s

Clinical 32% Hospitals, Independent Labs, Core Labs, Reference Labs, CLIA Labs

Academic 22% Centers of Excellence, Precision Medicine Institutes, Universities, Research Institutes

Government 5% Regulatory Bodies, Institutions, Policy Makers

Other 3% Healthcare Providers/ Healthcare Agencies/ Patient Advocate Groups

P E R S O N A L I Z E

A U G U S T 2 1 - 2 4 , 2 0 1 7 H I L T O N S A N D I E G O B A Y F R O N T

2 N D A N N U A L P R E C I S I O N M E D I C I N E L E A D E R S S U M M I T

“It was exciting to participate in the first Precision Medicine Leaders’ Summit. The Journal of Precision Medicine gathered many pioneers in the field and created

an open and candid forum to discuss the advancement of precision medicine. We not only covered current FDA and Congressional thinking on diagnostics, but also had the opportunity to explore forward-looking policies that would

help ensure the full realization of precision medicine. I’ll definitely be back next year and look forward to reconnecting with many of these innovators.”

Wade Ackerman, Partner in the Food, Drug, and Device Group at Covington & Burling LLP

A U G U S T 2 1 - 2 4 , 2 0 1 7 H I L T O N S A N D I E G O B A Y F R O N T

2 N D A N N U A L P R E C I S I O N M E D I C I N E L E A D E R S S U M M I T

The 2nd Annual Precision Medicine Leaders’ Summit offers sponsorship and exhibiting opportunities to companies or organizations wishing to reach

key decision makers in the Precision Medicine field. There are a limited number of these varied offerings. To obtain more information please contact

Damian Doherty at ddoherty@thejournalofprecisionmedicine.com orNigel Russell at nrussell@thejournalofprecisionmedicine.com

INDUSTRY

ACADEMIC

CL IN ICAL

GOVERNMENT

OTHER

P E R S O N A L I Z E

38%22%32%

AbbVie Research Fellow

Abbvie, Inc. Associate Scientific Director

Abbvie, Inc. Director

Acetylon Pharmaceuticals CMO & SVP Clinical Development

Affimed Therapeutics Chief Medical Officer

Agios Pharmaceuticals Vice President - Chemistry

Alexion VP Clin Ops

Amgen Inc. Director Preclinical

Amgen Inc. Exec Medical Dir Med Sciences

Ariad Pharmaceuticals Experimental/Computational Biologist

ARUP Laboratories Medical Director and Professor

AstraZeneca Translational Genomics Lead

AstraZeneca VP, Immuno-Oncology

AstraZeneca Canada Inc. Medical Advisor Oncology; Urology and Infection

AstraZeneca Bioscience Director

AstraZeneca R&D Boston Executive Director

ASU Chief Scientist

Avera Health Cancer Genomics Investigator

Basilea Pharmaceutica International Ltd. Head of Cancer Biology

Bayer Healthcare Global Clinical Leader

Bayer Pharma Ag Head Global Biomarker Strategy

Baylor College of Medicine Director

Biothera, Inc. Vice President Immunology

BMS SVP Head of Development Oncol

Brigham And Women’s Hosp. Clinical Fellow

Bristol-Myers Squibb Group Director; Pharmacodiagnostics

Bristol-Myers Squibb Director of Biostatistics

Bristol-Myers Squibb Company Group Medical Director

Broad Institute of MIT & Harvard Director; Genomics R&D and Clinical Development

Cancer Treatment Centers of America Senior Vice President; Personalized Medicine Operations

Catholic Health Initiatives Informatics Data Scientist

Cedars-Sinai Health System Vice PresidentP E R S O N A L I Z E

Reader Profile

P E R S O N A L I Z E

Celgene UK Assoc Dir, Medical Affairs

Cephalon Inc Director R&D

Cerner Corporation Genomics Strategist

Charite, Berlin, Germany Clinical Fellow

Children’s Cancer Institute Executive Director

Children’s Hosp. of Philadelphia Chair

Columbia Univ. Associate Research Scientist

Columbia Univ. Inst. for Cancer Genetics Director

Daiichi Sankyo Senior Director of Functional Genomics and Proteomics

Dana-Farber Cancer Inst. Clinical Fellow

Dana-Farber Cancer Inst. Associate Director

Deciphera Pharmaceuticals Chief Scientific Officer

Dicerna Pharmaceuticals Chief Scientific Officer

Eisai Inc. Director

Eisai Inc. Distinguished Scientist

Eli Lilly CSO

Eli Lilly Exec VP

Eli Lilly Senior Research Fellow

Fangsheng Pharmaceuticals CSO

FDA Biologist/Scientific Reviewer

FDA Investigator

FDA Medical Officer

Forma Therapeutics Senior Director; Pharmacology & Translational Biology

Forma Therapeutics Director Discovery Biology

Gan & Lee Pharmaceuticals Co., Ltd. CSO

Geisel School of Medicine Chair

Genentech Group Medical Director; USMA BioOncology

Genentech Sr. Manager; CDx

Genentech Inc. Assistant Medical Director

Genentech, Inc. Director

Genentech, Inc. Vice President- Hematology

Genetic Institute Acting lab director

Genetic Research Inst. Director

Genome Institute of Singapore Bioinformatics Specialist

Genome Institute of Singapore Senior Project Manager

Genome Technology Branch; NHGRI Senior Investigator

Genomic Health Doctor

Genomic Health Research Scientist

Genomics England CEO Genomics Enterprises

Georgetown Univ. School of Medicine Chair of Pathology

Georgetown University Director; Innovation Center for Biomedical Informatics

Gielad Sciences VP Biometrics

Glaxosmithkline Scientist

Glaxosmithkline Director, Oncology R&D

P E R S O N A L I Z E

Glaxosmithkline - Ware Director - Biophysical Sensors & Data Analytics

GSK VP

Halozyme Director Biotherapeutics Discovery

Halozyme Senior Medical Director

Hampton University Chair And Associate Professor

Henry Ford Health System Director; Molecular Pathology and Genomic Medicine

Hospital General de Mexico Medical Oncology

Human Longevity Senior VP

Icahn School of Medicine Clinical Fellow

Icahn School of Medicine at Mount Sinai Professor Emeritus

Imperial College London Professor of Chemical Biology

INC Research Executive Director; Clinical Dev; Early Phase Oncology

IncellDx Chief Business Officer/President

Incyte Corporation Principal Statistician

Inova Health System Director; Personalized Medicine Integration

Inova Health System Executive Vice President and Chief Technology Officer

Institut De Rechere Pierre Fabre Head of Translational Medicine

Janssen Research & Development VP & Global Head; Computational Sciences

Janssen Research & Development Associate Scientific Director

Janssen Research & Development Associate Scientific Director

Janssen Research & Development Global Head, Discovery Science

Johns Hopkins Medical Inst. Clinical Fellow

Keio University School of Medicine, Clinical Fellow

King’s College London Head Bioinformatics; NIHR BRC for Mental Health

Klaipeda University Hospital Head of Immunology Lab

Kolltan Pharmaceuticals Associate Director of Research

LSUHSC Cancer Center Director

Lytix Biopharma As Chief Medical Officer

Marshfield Clinic Research Foundation Director; CTR for Human Genetics

Massachusetts General Hospital Research Fellow

Mayo Clinic Director; Medical Genome Facility

Mayo Clinic Medical Director; Individualized Medicine

MD Anderson Cancer Center Medical Director; Laboratory Informatics

Medimmune Associate Director, R&D

Medimmune Vice President R&D

Medimmune Ltd. Director of Oncology Research

Merck Assoc. Director

Merck Associate Dir, Global Comm

Merck Clinical Director

Mirati Therapeutics President and CEO

Mission Health Director; Personalized Medicine

Mission Therapreutics VP Biology

Miyagi Cancer Ctr. Research Inst. Chief Res Fellow

P E R S O N A L I Z E

Moffitt Cancer Center EVP and Center Director

Moffitt Cancer Center Associate Center Director

Moffitt Cancer Center Center Director And Evp

Momenta Pharmaceuticals Vice President Research

Multi. Myeloma Research Foundation VP Translational Research

Myriad Genetics Inc. VP Medical Director Clinical Research

National Cancer Institute Deputy Director

National Cancer Institute Associate Chief

National Cancer Institute Biomedical Informatics

NIH Acting Director

NIH/NCI/CCR Director of Clinical Genomics

NNE Pharmaplan VP

NorthShore University Health System Division Head; Center for Medical Genetics

Northwestern University Assistant Director Clinical Services

Norwegian University Research Scientist

Novartis Global head of preclinical informatics

Novartis Assoc. Director

Novartis Institutes for Biomedical Research Global Head Oncology Bioinformatics

Novartis Oncology Associate Director

Novartis Oncology Group Lead

Novartis Director; Global Pipeline Diagnostic Strategy

Novartis Director of Clinical Research

Novartis Global Clinical Lead

Oncomed Pharmaceuticals, Inc. VP; Translational Medicine

Ontario Institute Director, Genome Technologies

Oregon Health & Science University Dir Computational Biology

Penn Medicine Clinical Director

Peter Maccallum Cancer Ctr. Director

Pfizer VP Enterprise Science & Technology

Pfizer VP Science Policy and Science Advocacy

Pfizer Chief of Staff, Global Oncolog

Pfizer Senior Director

Pfizer Associate Research Fellow

Pfizer Vice President

Princess Margaret Cancer Centre Director of Immune Therapy Program

Puma Biotechnology CEO

Queen’s Univ. Belfast Director

Quest Diagnostics Senior Cytogenetics Director

Quest Diagnostics VP Medical Affairs

Quintiles Head of Precision Medicine

Regeneron Pharmaceuticals Director Predictive Medicine; Translational Medicine

Regeneron Pharmaceuticals Executive Director

P E R S O N A L I Z E

Roche Head of Pharmacology

Roche Diagnostics GMBH Lab Head Genetics-Genomics

Rutgers- CINJ Associate Director Informatics

Rutgers-The Cancer Inst. of New Jersey Director of Precision Medicine

Sanford-Burnham Medical Research Inst. CEO

Sanofi Genzyme Sen. Director; Head Proteogenomics

Sanofi Onclogy Associate Vice-President

Sanofi R&D SVP Oncology

Seattle Genetics, Inc. Associate Dir, Cell Biology

Sequenom Vice President

St. Jude Children’s Res. Hosp. Chair

St. Jude Children’s Research Hospital Director; Division of Cancer Predisposition

Stanford Professor of Medicine and Genetics

Texas Tech University Chair

The Christ Hospital Director of Cancer Research

The Jackson Laboratory President and CEO

Thermofisher Scientific Director, Oncology R&D

Thomas Jefferson Univ. Chair And Professor

Tokai Pharmaceuticals Vice President; Head of Translational Medicine

Tokyo Medical University Chair And Professor

Trillium Therapeutics, Inc. Chief Medical Officer

University Medical Centre Groningen Professor of Medical Translational Genetics

Univ. of Maryland Greenebaum Cancer Ctr. Associate Director for Clinical Research

Univ. of Pennsylvania Chair

Univ. of Pennsylvania School of Medicine Director And Assoc. Professor

Univ. of Wisconsin Associate Research Specialist

University of Cambridge Academic Consultant in Experimental Cancer Therapeutics

University of Louisville Associate Professor/Research

University of Michigan Director Center for the Discovery of New Medicines

University of North Carolina Director; Center for Pharmacogenomics and Individualized Therapy

University of Oxford Clinical Director

MD Anderson Cancer Ctr. Fellow

Weill Cornell Med. College Associate Research Professor

Yale School of Medicine Assoc Professor of Medical Oncology

Job Profile

Research

Scientists

Clinical Scientists

BiomarkerR&D

Drug Discovery

Heads ofPathology

Heads of Research

Genetics

Directors of Precision Medicine

Drug SafetyHeads of

Translational Medicine

Heads of Clinical

R&D

Heads of Dx

Directors of Clinical

Trials

Computational

Heads of Experimental

Medicine

Proteomics

Genomics

Metabolomics

EpigenomicsMicrobiomics

IVD

Molecular

Companion

P E R S O N A L I Z E

ClinicalInformatics

Genetic Counselors

Head ofSequencing

ChiefMedicalOfficers

ResearchInformatics

‘Now that firm evidence exists for the diagnostic and clinical utility of genomic/precision medicine, there is a

strong need for a journal to help synthesize progress in this highly dynamic field.’

Print Rates

1/3 page $2,850 1/2 page $3,950 Full page $6,450 Double page spread $11,950 Outside back cover $9,950 Two Page Precision Profile $8,950

Impact pieces 4 page insert $9,150 2 page insert $7,050 Barn Door $12,450 Full page cover tip on $8,950 Belly wrap $12,500 Spreadmarker $12,500

P E R S O N A L I Z E

Stephen KingsmorePresident/CEO, Rady Pediatric Genomic and

Systems Medicine Institut

‘Successful implementation and incorporation of precision medicine in healthcare requires comprehensive and co-operative integration of scientists, government regulatory and policy makers, commercial stakeholders, payers and patients. A journal fully dedicated to Precision Medicine to cover these

issues is both timely and important.’

Online Rates

Email Blasts $450 per 1000 (minimum 3000 recipients) Email Blasts can be used to promote in house webinars, used as e-application notes, product launches, awareness of upcoming exhibitions or to promote video. We offer eTOC’s on a bimonthly basis

Mailing List Rental $200 per 1000 recipients

Webinars $12,000

We will produce, host and promote your webinar and will partner with you in sourcing Industry Opinion Leaders related to your area of technology/interest. We will arrange:- l Moderator. l Recording, promotion and rehearsal prior to the event. l Management of data capture through registration pre and post event. l On demand availability of webinar for 6 months. l Categorised in archive.

P E R S O N A L I Z E

Eric LaiSenior VP, Head of Pharmacogenomics & Companion Diagnostics,

Takeda Pharmaceuticals International, Inc.

Online Rates

Video $850 per month (Homepage)

Website Advertising

P E R S O N A L I Z E

Banner 11321 pxl x 240 pxl$950

Banner 2312 pxl x 802 pxl $750

Banner 3328 pxl x 482 pxl $550

Digital Media

The Journal of Precision Medicine has created an active environment on Linkedin and Twitter. Delivering our Snpits to an audience eager to learn more about this dynamic space, encouraging followers to engage in reading, sharing and participating in a continuous flow of dialogue, we aim to be an invaluable resource and platform to further discussion on the critical issues facing Pharma, Biotech and Diagnostic companies in the Personalised Precision Medicine landscape.

The Website offers new features and investigative snapshots of developments in the field of Precision Medicine. Our website is available at www.thejournalofprecisionmedicine.com and covers everything Precision Medicine from videos to news to interviews to editorial content - we also have an app on the App Store and will be on Google Play in 2017.

P E R S O N A L I Z E

P E R S O N A L I Z E

Specifications

Full Page

Half PageHorizontal

Half PageVertical

HalfIsland

ThirdVertical

ThirdIsland

ThirdHorizontal

Half Page Horizontal8”W x 4.75”H203mmW x 121mmH

Third Vertical2.57”W x 9.84”H65.5mmW x 250mmH

Half Island5.25”W x 7.375”H133mmW x 187mmH

Third Island5.25”W x 4.875”H133mmW x 124mmH

Third Horizontal8”W x 3”H203mmW x 76mmH

Half Page Vertical3.875”W x (9.84”H98mmW x 250mmH

Full Page9”W x 10.875”H Trim229mmW x 276mmH

9.25”W x 11.125”H Bleed235mmW x 283mmH

8.625”W x 10.5H Live Area

219mmW x 267mmH(Safe from Trim)

Double Page Spread

Double Page Spread18.5”W x 11.125”H (in bleed)

Belly Band19.25” x 5”D

Belly Band

P E R S O N A L I Z E

E-Newsletter dates for 2017

January 4th 11th

18th 25th

February 1st 8th

15th 22nd

March 1st 8th

15th 22nd29th

April 5th 12th

19th 26th

May 3rd 10th

17th 24th31st

June 7th 14th21st 28th

July 5th 12th

19th 26th

August 2nd 9th

16th 23rd30th

September 6th 13th

20th 27th

October 4th 11th

18th 25th

November 1st 8th

15th 22nd29th

December 6th 13th

20th 27th

Leaderboard $1000

Boom Box Advertisment

$750

SponsoredContent

$850

P E R S O N A L I Z E

GenomicsEpigeneticsMol DxProteomics

Transcriptomics

Companion Dx

Biomarkers

Genetic TestingGene Therapy

Clinical InformaticsDigital HealthSynthetic Biology

Clinical Chemistry

3D Bioprinting

Reimbursement

NEXT GENERATION SEQUENCING

Artificial IntelligenceRegenerative

MedicineLegal, Bioethical and Social Implications of Precision Medicine

Big Data

Drug Safety/Dosage

Gene Based Clinical Trials

Editorial Calendar for 2017

Precision Tools will cover a wide range of technologies and approaches critical to the success

of Precison Medicine. Here are some of the areas but not limited to, that we shall cover.

Cognoscienti will cover issues relating to bioethics, politics, regulation, policy, patient advocacy.

Field Notes is designed to expand upon some news centering around progress being made in

a particular therapeutic area.

SNPshot will cover an area of growing scientific or technological development.

The Hub will centre on an area of innovation around the globe that is promoting inward

investment and advancing science and technology in the pursuit of precision therapeutics.

We shall cover a broad range of topics in each issue, some of these are listed below.

P E R S O N A L I Z E

Editorial Features for 2017

Field Notes

Jan-Feb: Precision BioBanking

Mar-Apr: Rare Diseases

May-Jun: Oncology

July-Aug: Infectious Diseases

Sept-Oct: Neurodegenerative Diseases

Nov-Dec: Pediatric Diseases

2020

Jan-Feb: TBC

Mar-Apr: TBC

May-Jun: TBC

July-Aug: TBC

Sept-Oct: TBC

Nov-Dec: TBC

SNPshot

Jan-Feb: Microbiome

Mar-Apr: Big Data

May-June: NGS

July-Aug: Genomics

Sept-Oct: Digital Pathology

Nov-Dec: Pharmacogenomics

The Hub

Jan-Feb: Dublin, Ireland

Mar-Apr: Qatar

May-June: Stockholm

July-Aug: San Diego

Sept-Oct: Singapore

Nov-Dec: South Africa

Event Schedule

These are some of the conferences we will be attending or exhibiting at in 2017.

ACMG 22-24 March 2017 Phoenix, AZ

AACR 1-5 April 2017 Washington, DC

ASCO 3-7 June 2017 Chicago, IL

Bio International Convention 6-9 June 2017 San Diego, CA

AACC 30 July-3 August 2017 San Diego, CA

2nd Annual Precision Medicine Leaders Summit 21-24 August 2017 San Diego, CA

ASHG 17-21 October 2017 Orlando, FL

AMP 16-18 November 2017 Salt Lake City, UT

P E R S O N A L I Z E

Damian Doherty Co-Founder & Editor in ChiefThe Journal of Precision MedicineThe Atrium, Curtis Road, Dorking, Surrey RH4 1XA UKT: +44 (0)1306 646449 F: +44 (0)1306 471903E: ddoherty@thejournalofprecisionmedicine.comwww.thejournalofprecisionmedicine.comwww.pmls2017.com

Nigel Russell Co-Founder & PresidentThe Journal of Precision Medicine10388 Tremont Drive, Fishers, IN 46037 USAT: 317-762-7220 F: 317-863-1256nrussell@thejournalofprecisionmedicine.comwww.thejournalofprecisionmedicine.comwww.pmls2017.com

P E R S O N A L I Z E

Todd Hager Western US Sales ManagerThe Journal of Precision Medicine2446 NW Hemmingway Street Bend, OR 97703T: 541-350-5104 F: 317-863-1256E: thager@thejournalofprecisionmedicine.comwww.thejournalofprecisionmedicine.comwww.pmls2017.com